St. Jude-VIVA Survivorship Series 2

 St. Jude-VIVA Survivorship Series 2

Friday, 7th Oct 2022 - 5th March 2023

08:30 PM - 10:00 PM (UTC+8 | SGT)  |  Check your Time Zone


Register Now


VIVA Foundation for Children with Cancer in collaboration with the St. Jude Children’s Research Hospital is excited to bring a new series of the St Jude-VIVA Survivorship from 7th October to 5th March 2023.

The St Jude-VIVA Survivorship seeks to bring together international experts to educate healthcare professionals on the best practices and standard of care for childhood cancer survivorship. We seek to advance the importance of survivorship care and to provide a platform for paediatric oncology practitioners of diverse backgrounds to convene and address the challenges associated with the delivery of survivorship care.

For series 2, we will be featuring case presentations followed by a discussion of the data informing current clinical practice recommendations and guidelines, as well as the implementation of these protocols across diverse healthcare systems around the globe.

For more information visit


Survivorship Series 2 Meeting footprints 1


 If you can't make it, you can still register to receive a copy of the webinar recording.

Medical professionals in Singapore are eligible for CME/CNE/CPE credits for attending this webinar

Credits and Certificates of Attendance will only be issued for those who are able to attend the live session and are in adherence with VIVA's Attendance Policy.


Dr Melissa Hudson

Dr Melissa Hudson

Member, St. Jude Faculty
Director, Cancer Survivorship Division
Co-Leader, Cancer Control & Survivorship Program
The Charles E. Williams Endowed Chair of Oncology-Cancer Survivorship
St. Jude's Children Research Hospital


Dr Melissa M. Hudson is currently a Member and Director of the Cancer Survivorship Division in the Department of Oncology at St. Jude Children’s Research Hospital where she holds the Charles E. Williams Endowed Chair of Oncology-Cancer Survivorship. She directs the After Completion of Therapy Program, which now monitors over 6000 long-term childhood cancer survivors treated on St. Jude trials. Dr Hudson serves as Co-Chair of the Children’s Oncology Group Long-Term FollowUp Guidelines for Survivors of Childhood, Adolescent and Young Adult Cancer and Co-Chair of the International Late Effects of Childhood Cancer Guideline Harmonization Group. She is also the Chair of the Childhood Cancer Survivor Study Education Committee. She works collaboratively with multidisciplinary investigators at St. Jude and within COG, IGHG and the CCSS in research initiatives evaluating biomedical and psychosocial outcomes among childhood cancer survivors and translating data from health outcomes research into evidence-informed clinical practice guidelines and interventions to improve the quality and duration of survival after childhood cancer. She has published widely on her research initiatives in paediatric Hodgkin lymphoma, late treatment sequelae after childhood cancer, and health education of childhood cancer survivors.